Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Patent CN102066355B reveals a novel one-pot synthesis for Dabigatran intermediates, offering significant cost reduction in API manufacturing and enhanced supply chain reliability for global pharmaceutical partners.
Advanced asymmetric coupling patent enables high-purity chiral alkyne production with significant cost reduction and supply chain reliability for global pharmaceutical intermediates manufacturing.
Patent CN109438288B discloses a green synthesis for N-nitrone aromatic amides. This report analyzes cost reduction and supply chain reliability for pharmaceutical manufacturers.
Patent CN102452972B details high-purity oxiracetam synthesis. Offers cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing partners.
Patent CN100509748C reveals efficient purification for pharmaceutical intermediates. Achieve cost reduction and supply chain reliability with advanced inorganic base catalysis.
Patent CN109053780A reveals a low-cost Raney Nickel oxidation route for Acalabrutinib intermediates, offering high purity and scalable supply chain solutions for global pharmaceutical manufacturers.
Patent CN104561136B enables high-yield chemo-enzymatic synthesis. Reduces cost and improves supply chain reliability for pharmaceutical intermediates.
Novel L-threonine aldolase enables green synthesis of antibiotic intermediates with high stereoselectivity and reduced environmental impact.
Patent CN107304179B details a novel synthesis for LCZ696 intermediates featuring improved stereocontrol and yield. Ideal for reliable pharmaceutical intermediate suppliers seeking scalable routes.
Patent CN111018928A reveals a novel 2-step synthesis for high-purity gastrodin hemihydrate, offering significant cost reduction and scalable manufacturing for global supply chains.
Novel low-temperature process achieves 99.3% purity. Reduces waste and avoids carcinogenic solvents. Ideal for API manufacturing cost reduction.
Patent CN104530041B reveals efficient quinolizidinone synthesis. Offers supply chain stability and cost reduction for pharmaceutical intermediate manufacturing partners globally.
Patent CN113816925A reveals a high-yield Trifarotene synthesis route. Eliminating n-butyllithium enhances safety and reduces manufacturing costs for global supply chains.
Patent CN109553595A reveals mild chiral gamma-butyrolactone synthesis. Reduces cost and improves supply chain reliability for pharmaceutical intermediates.
Patent CN115073252B details a novel Mitsunobu synthesis for 13C-Mexaxetine. This breakthrough ensures >99% isotopic purity and streamlined purification for reliable diagnostic reagents.
Novel patent CN111978188B details high-purity Mexiletine Impurity C synthesis. Offers stable supply chain and cost-effective manufacturing for quality control.
Patent CN103589665B reveals Rhodococcus qingshengii strain for high-purity (S)-CHBE production. Offers mild conditions and cost reduction in pharmaceutical intermediate manufacturing.
Novel electrophilic substitution route for 3-hydroxymethyl-4-hydroxymandelic acid. Reduces steps, lowers cost, ensures high purity for asthma medication supply chains.
Novel synthesis route for penehyclidine hydrochloride ensures high purity and safety. Ideal for reliable pharmaceutical intermediates supplier partnerships.
Patent CN115073351A reveals a green, water-based method for 3,3'-bisindolylmethanes using ion-pair catalysis, offering cost reduction and high purity for pharmaceutical manufacturing.